AVSOLA
NDC 55513-670, infliximab-axxq, injection, powder, lyophilized, for solution, from Amgen, Inc.
- Product NDC
- 55513-670
- Status
- Listed
- Labeler
- Amgen, Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761086
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55513-670 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLIXIMAB100 mg/10mL
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55513-670-01 | 55513067001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
| 55513-670-21 | 55513067021 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-670-21) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/de34bcb7-b524-45c8-9181-61c6f48d540eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55513-670
Use it
Look up 55513-670 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55513-670 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55513-670. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.